Miruvor
Sign up
Long COVID Outcome unclear

Long COVID, stopped low-dose naltrexone after two weeks as side effects persisted

Condition
Long COVID
At worst
Not stated
Ill for
Not stated
Last post
Jan 2026
In their words
Read from 2 of their posts and comments; links to the 2 this page draws on

Request to remove this story

Summary

The user tried low-dose naltrexone at 0.1-0.25 mg and lasted two weeks before stopping because side effects did not improve. They later suspected that a recurring VZV infection might explain the reaction, and that other immunomodulating drugs had caused similar side effects, but called it only a suspicion.

Ask Miruvor AI

Asking aboutOrchid 86202’s story

What they tried

Also tried

Their words about each treatment
  • LDN · WorseI experienced the same side effects when I tried LDN at 0.1-0.25 mg. I only lasted 2 weeks before giving up, the side effects never improving during this time. In context ↗

Their path

They say too little about how ill they were at each step to draw it on the severity scale, so the steps are listed as they describe them. Dates are when they posted.

WhenWhat happenedAfter
2026-01-16tried LDN and stopped after two weeks of side effectsI experienced the same side effects when I tried LDN at 0.1-0.25 mg. I only lasted 2 weeks before giving up, the side effects never improving during this time. In context ↗Low-dose naltrexone
2026-01-24still only suspected VZV reactivation as explanation for side effectsIt's only a suspicion, though. I'll report back if I come to a definite conclusion. In context ↗

Adverse events

  • Low-dose naltrexone“I experienced the same side effects when I tried LDN at 0.1-0.25 mg. I only lasted 2 weeks before giving up, the side effects never improving during this time.” In context ↗ Side effects
  • “I had similar side effects with other immunemodulating drugs” In context ↗ Side effects

Ask Miruvor AI

Asking aboutOrchid 86202’s story

A little hope, every Sunday

New recovery stories and data-driven research on ME/CFS and long COVID. Ideas worth considering, and the evidence behind them.

Free · Unsubscribe anytime